Afsal Kolloli

Afsal Kolloli

Auto-generated profile, based on publicly available information

Afsal Kolloli

Rutgers Health, New Jersey Medical School, N.J., USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2024 in The Journal of Immunology
Verified
Journal Article
Closed access
Ranjeet KumarRanjeet Kumar
Ranjeet Kumar
AKAfsal Kolloli
Afsal Kolloli
SSSelvakumar Subbian
Selvakumar Subbian
DKDeepak Kaushal
Deepak Kaushal
LSLanbo Shi
Lanbo Shi
STSanjay Tyagi
Sanjay Tyagi
Granulomas are an important hallmark of Mycobacterium tuberculosis infection. They are organized and dynamic structures created when immune cells assemble around the sites of infection in the lungs that locally restrict M. tuberculosis growth and the host’s inflammatory responses. The cellular architecture of granulomas is traditionally studied by immunofluorescence labeling of surface markers on the host cells. However, very few Abs are available for model animals used in tuberculosis research, such as nonhuman primates and rabbits, and secreted immunological markers such as cytokines cannot be imaged in situ using Abs. Furthermore, traditional phenotypic surface markers do not provide sufficient resolution for the detection of the many subtypes and differentiation states of immune cells. Using single-molecule fluorescence in situ hybridization (smFISH) and its derivatives, amplified smFISH and iterative smFISH, we developed a platform for imaging mRNAs encoding immune markers in rabbit and macaque tuberculosis granulomas. Multiplexed imaging for several mRNA and protein markers was followed by quantitative measurement of the expression of these markers in single cells. An analysis of the combinatorial expressions of these markers allowed us to classify the cells into several subtypes, and to chart their densities within granulomas. For one mRNA target, hypoxia-inducible factor-1α, we imaged its mRNA and protein in the same cells, demonstrating the specificity of the probes. This method paves the way for defining granular differentiation states and cell subtypes from transcriptomic data, identifying key mRNA markers for these cell subtypes, and then locating the cells in the spatial context of granulomas.

1 July 2026 in bioRxiv
Verified
Preprint
Open access
CAChoudhary Alok
Choudhary Alok
DPDeendayel Patel
Deendayel Patel
WHWilliam Honnen
William Honnen
AKAfsal Kolloli
Afsal Kolloli
CRCharles Reichman
Charles Reichman
APAbraham Pinter
Abraham Pinter
Lipoarabinomannan (LAM) is a useful biomarker for detection of M. tuberculosis infection and disease. Related antigens can be detected in urine samples of TB patients by combinations of monoclonal anti-bodies (mAbs) directed against specific epitopes expressed in LAM. While sensitive for samples from patients with active TB disease who have HIV-1 co-infections, these assays are less effective for other populations, and there is therefore a need for more sensitive antibodies that can improve the sensitivity of these assays. Here we characterize the antigen and epitope specificities, sequence diversity and isotype dependencies of eight LAM-specific human mAbs that target five distinct arabinose- and man-nose-dependent epitopes present in LAM and lipoarabinomannan (LM). Whereas all of the mAbs rec-ognized ManLAM, only a few, including A194-01, consistently detected antigens in TB+ urine samples. Converting A194-01 from the IgG1 to the IgM isotype resulted in broader recognition of poly-Ara glycan epitopes, and increased sensitivity for clinical antigens when combined with several capture reagents, including RU95-C1, a novel antibody targeting the mannan domain of LAM. These results define novel epitopes that are differentially expressed in bacterial and urinary forms of LAM, and identify novel anti-body combinations which possess enhanced diagnostic utility for clinical forms of LAM.